Chronic kidney disease stages 1-3 increase the risk of venous thrombosis

被引:41
作者
Ocak, G. [2 ]
Verduijn, M. [2 ]
Vossen, C. Y. [2 ]
Lijfering, W. M. [2 ]
Dekker, F. W. [2 ]
Rosendaal, F. R. [2 ,3 ]
Gansevoort, R. T. [1 ]
Mahmoodi, B. K. [4 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, NL-9700 RB Groningen, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Thrombosis & Haemostasis, Leiden, Netherlands
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Haematol, Div Haemostasis & Thrombosis, NL-9700 RB Groningen, Netherlands
关键词
chronic kidney disease; kidney function; venous thrombosis; GLOMERULAR-FILTRATION-RATE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; MICROALBUMINURIA; MORTALITY; COHORT; THROMBOEMBOLISM; CLASSIFICATION; ASSOCIATION; POPULATION;
D O I
10.1111/j.1538-7836.2010.04048.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>Background: End-stage renal disease has been associated with venous thrombosis (VT). However, the risk of VT in the early stages of chronic kidney disease (CKD) has not yet been investigated. The aim of this study was to investigate whether CKD patients with stage 1-3 disease are at increased risk of VT. Methods: Eight thousand four hundred and ninety-five subjects were included in a prospective cohort study, in which renal function and albuminuria were assessed, starting in 1997-1998, and were followed for the occurrence of VT until 1 June 2007. CKD patients were staged according to the Kidney Disease Outcomes Quality Initiative guidelines, on the basis of 24-h urine albumin excretion and estimated glomerular filtration rates. Objectively verified symptomatic VT was considered to be the endpoint. Results: Of the 8495 subjects, 243 had CKD stage 1, 856 CKD stage 2, and 491 CKD stage 3. During a median follow-up period of 9.2 years, 128 individuals developed VT. The hazard ratios (HRs) for CKD stages 1, 2 and 3 were, respectively, 2.2 [95% confidence interval (CI) 0.9-5.1], 1.9 (95% CI 1.1-3.1) and 1.6 (95% CI 0.9-2.8) relative to those without CKD after adjustment for age, sex, body mass index, hypertension, diabetes, malignancy, and high-sensitivity C-reactive protein. Subjects with CKD stage 3 and albuminuria (>= 30 mg d-1) had an adjusted HR of 3.0, and subjects with CKD stage 3 without albuminuria had an adjusted HR of 1.0. Conclusions: CKD stages 1 and 2, and CKD stage 3 in the presence of albuminuria, are risk factors for VT. The risk of VT is more related to albuminuria than to impaired glomerular filtration rate.
引用
收藏
页码:2428 / 2435
页数:8
相关论文
共 32 条
[1]   Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion [J].
Brantsma, Auke H. ;
Bakker, Stephan J. L. ;
Hillege, Hans L. ;
de Zeeuw, Dick ;
de Jong, Paul E. ;
Gansevoort, Ronald T. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (12) :3851-3858
[2]   Prevalence of chronic kidney disease in the United States [J].
Coresh, Josef ;
Selvin, Elizabeth ;
Stevens, Lesley A. ;
Manzi, Jane ;
Kusek, John W. ;
Eggers, Paul ;
Van Lente, Frederick ;
Levey, Andrew S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (17) :2038-2047
[3]   Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency [J].
Culleton, BF ;
Larson, MG ;
Wilson, PWF ;
Evans, JC ;
Parfrey, PS ;
Levy, D .
KIDNEY INTERNATIONAL, 1999, 56 (06) :2214-2219
[4]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[5]   Chronic kidney disease and venous thromboembolism: a prospective study [J].
Folsom, Aaron R. ;
Lutsey, Pamela L. ;
Astor, Brad C. ;
Wattanakit, Keattiyoat ;
Heckbert, Susan R. ;
Cushman, Mary .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (10) :3296-3301
[6]   C-reactive protein and venous thromboembolism A prospective investigation in the ARIC cohort [J].
Folsom, Aaron R. ;
Lutsey, Pamela L. ;
Astor, Brad C. ;
Cushman, Mary .
THROMBOSIS AND HAEMOSTASIS, 2009, 102 (04) :615-619
[7]   Cross-classification of microalbuminuria and reduced glomerular filtration rate - Associations between cardiovascular disease risk factors and clinical outcomes [J].
Foster, Meredith C. ;
Hwang, Shih-Jen ;
Larson, Martin G. ;
Parikh, Nisha I. ;
Meigs, James B. ;
Vasan, Ramachandran S. ;
Wang, Thomas J. ;
Levy, Daniel ;
Fox, Caroline S. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (13) :1386-1392
[8]   Evaluation of measures of urinary albumin excretion [J].
Gansevoort, Ronald T. ;
Brinkman, Jacoline ;
Bakker, Stephan J. L. ;
De Jong, Paul E. ;
de Zeeuw, Dick .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 164 (08) :725-727
[9]   Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I [J].
Garg, AX ;
Clark, WF ;
Haynes, RB ;
House, AA .
KIDNEY INTERNATIONAL, 2002, 61 (04) :1486-1494
[10]   A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism [J].
Glynn, Robert J. ;
Danielson, Eleanor ;
Fonseca, Francisco A. H. ;
Genest, Jacques ;
Gotto, Antonio M., Jr. ;
Kastelein, John J. P. ;
Koenig, Wolfgang ;
Libby, Peter ;
Lorenzatti, Alberto J. ;
MacFadyen, Jean G. ;
Nordestgaard, Borge G. ;
Shepherd, James ;
Willerson, James T. ;
Ridker, Paul M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18) :1851-1861